Injective (INJ) price has surged by 30% in the past week and 14% in the last 24 hours, with trading volume up by over 250% to $274 million. Bullish technical indicators like an overbought RSI at 80.6 and a BBTrend at its highest levels since November 2024 support this strong performance. If a golden cross occurs, INJ could target $26.5, $29.4, and potentially $35.2, but risks exist if support levels fail. The RSI at 80.6 indicates overbought conditions, signaling potential short-term gains but also caution for a cooldown. INJ's BBTrend at 11.05, near its recent peak, shows strong bullish momentum. A potential golden cross could reignite buying momentum towards $26.5 and beyond. However, failure to materialize could lead to downside pressure, with critical support at $23.98. Traders should monitor for sustainability of momentum or a possible consolidation phase. Read more AI-generated news on: https://app.chaingpt.org/news